Business

Predicting Growth in Ultrasound Markets—Six Predictions

With healthcare costs continuing to rise, affordable and accurate imaging and diagnosis achieved through ultrasound will continue to attract patients, according to a new market report from Fact.MR. The report on the global market for ultrasound systems projects steady growth for the market from 2017 to 2022, from a value of $6 billion in 2017 to $7.8 billion toward the end of 2022 — a compound annual growth rate (CAGR) of 5.5 percent.

Read more here.

AHA calls on hospitals, health systems to compete with ‘disruptors’

In a recent speech, Richard Pollack, President and CEO of the American Hospital Association noted that new entrants into the healthcare sector, such as Amazon, Apple and Google, are poised to serve as “disruptors” in the industry.  “We are seeing historic—if not unprecedented—change across the entire healthcare landscape,” Pollack told an AHA forum in Washington. “There’s no doubt that more engaged consumers, advances in technology and new entrants add up to a dramatically changed healthcare landscape.”  Pollack went on to say that one of the most significant market forces that is driving innovation and transforming healthcare is that “patients and their families simply want care that is more convenient—they want it when and where they want it—and, they are becoming much more engaged in directing their own care.”

Read more here.

Survey: Healthcare executives spotlight the sweeping policy changes they see coming for the industry

Hooper, Lundy & Bookman, PC, a healthcare law firm, polled more than 220 healthcare executives from across the spectrum and found 74% believe significant policy change is either very likely or somewhat likely in the next two years.

Read more here.

Philips kicks off new year with realigned business segments

When speaking about the growth of the Image-Guided Therapy businesses, Frans van Houten, CEO of Royal Philips, said in a statement. “To strengthen our leadership in this fast-growing market, we have significantly invested in our R&D programs, which resulted in the launch of the very successful Azurion next-generation image-guided therapy platform, and the acquisitions of Volcano, Spectranetics and, most recently, EPD Solutions, which enabled the expansion into smart devices such as diagnostic and therapeutic catheters.”

Read more here.

Page 1 of 5012345...102030...Last »